Allspring Global Investments Holdings LLC Has $205.87 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Allspring Global Investments Holdings LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 392,946 shares of the medical equipment provider’s stock after selling 30,690 shares during the period. Allspring Global Investments Holdings LLC owned 0.11% of Intuitive Surgical worth $205,873,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Avidian Wealth Enterprises LLC boosted its holdings in Intuitive Surgical by 37.3% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 901 shares of the medical equipment provider’s stock valued at $470,000 after acquiring an additional 245 shares during the last quarter. Great Lakes Retirement Inc. lifted its position in Intuitive Surgical by 1.6% during the 4th quarter. Great Lakes Retirement Inc. now owns 3,215 shares of the medical equipment provider’s stock valued at $1,678,000 after purchasing an additional 50 shares during the period. Capital Advisors Inc. OK boosted its stake in shares of Intuitive Surgical by 1.5% in the 4th quarter. Capital Advisors Inc. OK now owns 129,751 shares of the medical equipment provider’s stock valued at $67,725,000 after purchasing an additional 1,858 shares during the last quarter. Certuity LLC grew its position in shares of Intuitive Surgical by 45.3% during the 4th quarter. Certuity LLC now owns 1,932 shares of the medical equipment provider’s stock worth $1,008,000 after buying an additional 602 shares during the period. Finally, Leavell Investment Management Inc. raised its stake in shares of Intuitive Surgical by 0.7% during the fourth quarter. Leavell Investment Management Inc. now owns 3,556 shares of the medical equipment provider’s stock worth $1,856,000 after buying an additional 25 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Finally, Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $591.65 on Wednesday. The firm has a market cap of $210.73 billion, a price-to-earnings ratio of 92.30, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock’s 50-day moving average is $555.91 and its 200-day moving average is $515.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.